FOXC2 pathogenetic variant has been identified in cases with LDS to impair transcriptional activity and cell proliferation [26] through VEGF-C/VEGFR3 signaling pathway commonly correlated with primary lymphedema, lymphatic valve formation and other lymphatic malformations [27]. The gene discussed is FOXC2; the disease is lymphedema.